Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.bbrc.2020.08.086

http://scihub22266oqcxt.onion/10.1016/j.bbrc.2020.08.086
suck pdf from google scholar
32977949!7447262!32977949
unlimited free pdf from europmc32977949    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32977949  :  Publisher

suck abstract from ncbi

pmid32977949
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage #MMPMID32977949
  • Shi TH; Huang YL; Chen CC; Pi WC; Hsu YL; Lo LC; Chen WY; Fu SL; Lin CH
  • Biochem Biophys Res Commun 2020[Dec]; 533 (3): 467-473 PMID32977949show ga
  • The coronavirus disease 2019 (COVID-19) pandemic caused by 2019 novel coronavirus (2019-nCoV) has been a crisis of global health, whereas the effective vaccines against 2019-nCoV are still under development. Alternatively, utilization of old drugs or available medicine that can suppress the viral activity or replication may provide an urgent solution to suppress the rapid spread of 2019-nCoV. Andrographolide is a highly abundant natural product of the medicinal plant, Andrographis paniculata, which has been clinically used for inflammatory diseases and anti-viral therapy. We herein demonstrate that both andrographolide and its fluorescent derivative, the nitrobenzoxadiazole-conjugated andrographolide (Andro- NBD), suppressed the main protease (M(pro)) activities of 2019-nCoV and severe acute respiratory syndrome coronavirus (SARS-CoV). Moreover, Andro-NBD was shown to covalently link its fluorescence to these proteases. Further mass spectrometry (MS) analysis suggests that andrographolide formed a covalent bond with the active site Cys(145) of either 2019-nCoV M(pro) or SARS-CoV M(pro). Consistently, molecular modeling analysis supported the docking of andrographolide within the catalytic pockets of both viral M(pro)s. Considering that andrographolide is used in clinical practice with acceptable safety and its diverse pharmacological activities that could be beneficial for attenuating COVID-19 symptoms, extensive investigation of andrographolide on the suppression of 2019-nCoV as well as its application in COVID-19 therapy is suggested.
  • |Betacoronavirus/enzymology[MESH]
  • |Catalytic Domain[MESH]
  • |Coronavirus 3C Proteases[MESH]
  • |Cysteine Endopeptidases/chemistry/*metabolism[MESH]
  • |Diterpenes/chemistry/*pharmacology[MESH]
  • |Fluorescent Dyes/chemistry/pharmacology[MESH]
  • |Molecular Docking Simulation[MESH]
  • |Protease Inhibitors/*chemistry/*pharmacology[MESH]
  • |Protein Conformation[MESH]
  • |Protein Multimerization[MESH]
  • |SARS Virus/enzymology[MESH]
  • |SARS-CoV-2[MESH]
  • |Viral Nonstructural Proteins/*antagonists & inhibitors/chemistry/*metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    467 3.533 2020